Update of ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2.

PC Fragkou, G De Angelis, G Menchinelli… - Clinical Microbiology …, 2023 - europepmc.org
… In the current update of the ESCMID COVID-19 Guidelines on diagnostic testing we present
the revised recommendations for the use of RADTs over the reference standard laboratory-…

ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting

E Carrara, DSY Ong, K Hussein, S Keske… - Clinical Microbiology …, 2022 - Elsevier
… The general principles and methodology applied have been described in the first paper
of the ESCMID guidelines for COVID-19–related clinical topics [7]. A total of nine PICOs (…

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

P Koehler, M Bassetti, A Chakrabarti… - The Lancet Infectious …, 2021 - thelancet.com
… Our aim is to provide definitions for clinical research and up-to-date recommendations for
clinical management of the diagnosis and treatment of COVID-19-associated pulmonary …

Should remdesivir be recommended in France in the early stage of COVID-19

M Martin - International Journal of Infectious Diseases, 2022 - ijidonline.com
guideline for hospitalised patients with noncritical COVID-19 (… of Clinical Microbiology and
Infectious Diseases) guidelinesrecommendations for patients with mild or severe COVID-19

Recommendations for dosing of repurposed COVID-19 medications in patients with renal and hepatic impairment

F Marra, EJ Smolders, O El-Sherif, A Boyle, K Davidson… - Drugs in R&D, 2021 - Springer
… Dosing of drugs used to treat COVID-19 in patients with renal or … recommendations were
produced to provide guidance to clinicians worldwide who are treating patients with COVID-19, …

Guidelines adaptation to the COVID-19 outbreak for the management of hepatocellular carcinoma

R Santambrogio, G Farina, V D'Alessandro… - … & Advanced Surgical …, 2021 - liebertpub.com
Recommendations. However, the risk of patients' exposure to COVID-19 has forced us to
change the treatment … The other 10 patients are alive, and they performed their follow-up with …

[HTML][HTML] Recommendations for antibacterial therapy in adults with COVID-19–an evidence based guideline

E Sieswerda, MGJ De Boer, MMJ Bonten… - Clinical microbiology …, 2021 - Elsevier
… symptoms of upper respiratory tract infection to life-threatening pneumonia. Severe disease
… and European society of clinical Microbiology and infectious diseases (ESCMID) critically ill …

One world, one pandemic, many guidelines: management of liver diseases during COVID-19

S Bollipo, D Kapuria, A Rabiee, G Ben-Yakov, RN Lui… - Gut, 2020 - gut.bmj.com
… Most of these recommendations are based on expert consensus, as … recommendations
and discuss a consolidated approach to managing liver disease in the setting of COVID-19. We …

[HTML][HTML] Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective

AS Hanafy, S Abd-Elsalam - World Journal of Gastroenterology, 2020 - ncbi.nlm.nih.gov
… Severe COVID-19 is life threatening complications, mainly respiratory failure and the need
for mechanical ventilation, denoted by presence of tachypnea > 30/min, oxygen saturation ≤ …

International variation in the management of severe COVID-19 patients

E Azoulay, J De Waele, R Ferrer, T Staudinger… - Critical Care, 2020 - Springer
… to suggest personalized management for each clinical phenotype [6, 7]. … clinical expertise
and the experience of managing COVID-19 patients. Last, questions about specific treatments